Authors:
Dean, JA
Blanchette, VS
Carcao, MD
Stain, AM
Sparling, CR
Siekmann, J
Turecek, PL
Lillicrap, D
Rand, ML
Citation: Ja. Dean et al., von Willebrand Disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 (R) and a von Willebrand factor/collagen-binding assay, THROMB HAEM, 84(3), 2000, pp. 401-409
Authors:
Kinlough-Rathbone, RL
Perry, DW
Rand, ML
Packham, MA
Citation: Rl. Kinlough-rathbone et al., Responses to aggregating agents after cleavage of GPIb of human platelets by the O-sialoglycoprotein endoprotease from Pasteurella haemolytica - Potential surrogates for Bernard-Soulier platelets?, THROMB RES, 99(2), 2000, pp. 165-172
Authors:
Rand, ML
Packham, MA
Taylor, DM
Yeo, EL
Gemmell, CH
Patil, S
Lam, SCT
Citation: Ml. Rand et al., The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa, THROMB HAEM, 82(6), 1999, pp. 1680-1686
Authors:
Kinlough-Rathbone, RL
Perry, DW
Rand, ML
Packham, MA
Citation: Rl. Kinlough-rathbone et al., Most apyrase preparations are impure and contain inhibitors of cathepsin G: Suggestions for use of apyrase in preparation and stabilization of platelet suspensions, THROMB HAEM, 81(5), 1999, pp. 849-850
Authors:
Kinlough-Rathbone, RL
Perry, DW
Rand, ML
Packham, MA
Citation: Rl. Kinlough-rathbone et al., Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents, THROMB RES, 95(6), 1999, pp. 315-323
Authors:
Kinlough-Rathbone, RL
Perry, DW
Rand, ML
Packham, MA
Citation: Rl. Kinlough-rathbone et al., Role of secreted adenosine diphosphate in the synergistic effects of cathepsin G on human platelets, THROMB RES, 95(6), 1999, pp. 341-346
Citation: Ml. Rand et al., Use of the PFA-100 (R) in the assessment of primary, platelet-related hemostasis in a pediatric setting, SEM THROMB, 24(6), 1998, pp. 523-529